MTOR and colorectal carcinoma: It has been reported that SNHG7 acts as a ceRNA by sponging miR-34a, which controls the expression of the GALNT7 target gene and promotes the progression of colorectal cancer (CRC) via the PI3K/Akt/mTOR pathway [15].